Limbix
company
About
Limbix is a prescription digital therapeutics platform that provides mental health treatment for young people.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $15M
- Industries
- Biotechnology,Health Care,Medical,Medical Device,Therapeutics
- Founded date
- Oct 1, 2016
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Limbix is a prescription digital therapeutic company passionate about creating mental health treatments for adolescents. The Limbix team is uniquely suited to develop prescription digital therapeutics, as its diverse team of clinicians, product designers, researchers, and engineers understand the value of pairing clinical expertise with technological innovation. Their first digital therapeutic, SparkRx by Limbix, is available for licensed healthcare professionals to offer to patients nationwide. For more information about Limbix and SparkRx, please visit limbix.com and SparkRx.com.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$27M
Limbix has raised a total of
$27M
in funding over 2 rounds. Their latest funding was raised on
Dec 7, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 7, 2021 | Series A | $15M | 1 | — | — | Detail |
| May 5, 2020 | Series A | $9M | 1 | — | — | Detail |
| Nov 1, 2016 | Seed | $3M | 1 |
Sequoia Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Limbix is funded by 2 investors.
Gaingels
and Sequoia Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Gaingels
|
— | Series A |
|
Sequoia Capital
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
